Interventions to Improve Colorectal Cancer Screening
1 other identifier
interventional
404
1 country
1
Brief Summary
We will evaluate if we can increase colorectal cancer screening rates by directly sending screening tests to patients rather than waiting for them to come to clinic visits. We are also evaluating a new test--fecal immunochemical tests--which does not require patients to make dietary or medication changes. We will see if patients are more likely to complete these tests than the standard fecal occult blood tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2008
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 3, 2008
CompletedFirst Posted
Study publicly available on registry
June 6, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedResults Posted
Study results publicly available
August 26, 2014
CompletedMay 13, 2015
April 1, 2015
10 months
June 3, 2008
August 11, 2014
April 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Colorectal Cancer Screening
Completing fecal blood test within 90 days of enrolling
3 months
Study Arms (2)
Arm 1: Fecal Immunochemical Tests
EXPERIMENTALMailed fecal immunochemical tests
Arm 2: Fecal Occult Blood Tests
EXPERIMENTALMailed fecal occult blood tests
Interventions
Eligibility Criteria
You may qualify if:
- Eligible for stool-based colorectal cancer screening, followed in primary care clinic
You may not qualify if:
- Need for surveillance or screening colonoscopy
- limited life expectancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New Mexico VA Health Care System, Albuquerque, NM
Albuquerque, New Mexico, 87108-5153, United States
Related Publications (2)
Hoffman RM, Steel SR, Yee EF, Massie L, Schrader RM, Moffett ML, Murata GH. A system-based intervention to improve colorectal cancer screening uptake. Am J Manag Care. 2011 Jan;17(1):49-55.
PMID: 21348568RESULTHoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med. 2010 May-Jun;50(5-6):297-9. doi: 10.1016/j.ypmed.2010.03.010. Epub 2010 Mar 20.
PMID: 20307568RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Richard Hoffman, MD
- Organization
- New Mexico VA Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Richard M Hoffman, MD
New Mexico VA Health Care System, Albuquerque, NM
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2008
First Posted
June 6, 2008
Study Start
June 1, 2008
Primary Completion
April 1, 2009
Study Completion
April 1, 2009
Last Updated
May 13, 2015
Results First Posted
August 26, 2014
Record last verified: 2015-04